Small cell transformation in EGFR-mutated non-small cell lung cancer (EGFR plus NSCLC): Efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with platinum-based chemotherapy

被引：0

作者：

Saalfeld, F. C. ^{[1
]}

Moeller, J. ^{[1
]}

Michels, S. ^{[2
]}

Grohe, C. ^{[3
]}

Wiesweg, M. ^{[4
]}

Schubart, C. ^{[5
]}

Alt, J. ^{[6
]}

Griesinger, F. ^{[7
]}

Kauffmann-Guerrero, D. ^{[8
]}

Kulhavy, J. ^{[9
]}

Overbeck, T. R. ^{[10
]}

Pelusi, N. ^{[11
]}

Rohde, G. ^{[12
]}

Wesseler, C. ^{[13
]}

Vathiotis, I. ^{[14
]}

Veluswamy, R. ^{[15
]}

Illini, O. M. ^{[16
]}

Rothschild, S. I. ^{[17
]}

Christopoulos, P. ^{[18
]}

Wermke, M. ^{[1
]}

机构：

[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus Dresden, Clin Internal Med 1, Dresden, Germany

[2] Univ Cologne, Univ Hosp, Dept Internal Med 1, Cologne, Germany

[3] ELK Berlin, Dept Resp Dis, Berlin, Germany

[4] Univ Duisburg Essen, Dept Med Oncol, West German Canc Ctr, Essen, Germany

[5] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Hosp Erlangen, Inst Pathol, Erlangen, Germany

[6] Johannes Gutenberg Univ Mainz, Dept Hematol & Oncol, Univ Med Ctr, Mainz, Germany

[7] Univ Med Oldenburg, Pius Univ Hosp, Dept Hematol & Oncol, Oldenburg, Germany

[8] Univ Munich LMU, Univ Hosp, Div Resp Med & Thorac Oncol, Dept Med, Munich, Germany

[9] Univ Hosp Wuerzburg, Comprehens Canc Ctr Mainfranken, Early Clin Trial Unit ECTU, Wurzburg, Germany

[10] Univ Gottingen, Univ Med Ctr Gottingen, Dept Hematol & Med Oncol, Gottingen, Germany

[11] Univ Hosp Bonn UKB, Inst Pathol, Bonn, Germany

[12] Johannes Wolfgang Goethe Univ, Med Clin 1, Dept Resp Med, Univ Klinikum Frankfurt, Frankfurt, Germany

[13] Klinikum Harburg, Asklepios Tumorzentrum Hamburg, Dept Pneumol, Hamburg, Germany

[14] Sotiria Thorac Dis Hosp Athens, Dept Med 3, Athens, Greece

[15] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Div Hematol & Med Oncol, New York, NY USA

[16] Klin Floridsdorf, Vienna Healthcare Grp, Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Vienna, Austria

[17] Cantonal Hosp Baden, Ctr Oncol Hematol, Baden, Switzerland

[18] Univ Heidelberg Hosp, Thoraxklin, Heidelberg, Germany

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.2369

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1336P

引用

页数：1

共 50 条

[1] Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy
Saalfeld, Felix Carl
Moeller, Johanna
Christopoulos, Petros
Wenzel, Carina
Rasokatf, Anna
Wangg, Xuejun Alice
Vathiotish, Ioannis
Koenigi, David
Illinij, Oliver
Grohe, Christian
Wiesweg, Marcel
Wesseler, Claas
Schubart, Christoph
Pelusi, Natalie
Rohde, Gernot
Overbeck, Tobias R.
Kirfel, Jutta
Alt, Juergen
Kauffmann-Guerrero, Diego
Griesingerv, Frank
Kulhavyw, Jonas
Allgaeuer, Michael
Klimovay, Anna
Schuetz, Maret
Aust, Daniela E.
Hochmairj, Maximilian J.
Rothschild, Sacha I.
Syrigos, Konstantinos N.
Veluswamy, Rajwanth
Michels, Sebastian
Stenzinger, Albrecht
Joehrens, Korinna
Wermke, Martin
EUROPEAN JOURNAL OF CANCER, 2024, 213
[2] Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?
Roviello, Giandomenico
Zanotti, Laura
Cappelletti, Maria Rosa
Gobbi, Angela
Dester, Martina
Paganini, Giovanni
Pacifico, Chiara
Generali, Daniele
Roudi, Raheleh
CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (01) : 15 - 20
[3] Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?
Giandomenico Roviello
Laura Zanotti
Maria Rosa Cappelletti
Angela Gobbi
Martina Dester
Giovanni Paganini
Chiara Pacifico
Daniele Generali
Raheleh Roudi
Clinical and Experimental Medicine, 2018, 18 : 15 - 20
[4] Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR-mutated non-small cell lung cancer
Yamada, Tadaaki
Hirai, Soichi
Katayama, Yuki
Yoshimura, Akihiro
Shiotsu, Shinsuke
Watanabe, Satoshi
Kikuchi, Toshiaki
Hirose, Kazuki
Kubota, Yutaka
Chihara, Yusuke
Harada, Taishi
Tanimura, Keiko
Takeda, Takayuki
Tamiya, Nobuyo
Kaneko, Yoshiko
Uchino, Junji
Takayama, Koichi
CANCER MEDICINE, 2019, 8 (04): : 1521 - 1529
[5] RICTOR signaling modulates the activity of EGFR tyrosine kinase inhibitors (TKI) in EGFR-mutated non-small cell lung cancer (NSCLC)
Fan, Ni
Zou, Yiyu
Halmos, Balazs
Perez-Soler, Roman
Cheng, Haiying
CANCER RESEARCH, 2019, 79 (13)
[6] Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors
Saboundji, Karima
Auliac, Jean-Bernard
Perol, Maurice
Francois, Geraldine
Janicot, Henri
Marcq, Marie
Dubos-Arvis, Catherine
Renault, Aldo
Guisier, Florian
Odier, Luc
Gervais, Radj
Chouaid, Christos
TARGETED ONCOLOGY, 2018, 13 (04) : 501 - 507
[7] Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors
Karima Saboundji
Jean-Bernard Auliac
Maurice Pérol
Géraldine François
Henri Janicot
Marie Marcq
Catherine Dubos-Arvis
Aldo Renault
Florian Guisier
Luc Odier
Radj Gervais
Christos Chouaïd
Targeted Oncology, 2018, 13 : 501 - 507
[8] Efficacy of Tyrosine Kinase Inhibitors in EGFR Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases
Flippot, R.
Auclin, E.
Biondani, P.
Le Rhun, E.
Adam, J.
Planchard, D.
Caramella, C.
Le Pechoux, C.
Lacroix, L.
Gazzah, A.
Mezquita, L.
Besse, B.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S467 - S467
[9] Research Trends of Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer: A Bibliometric Analysis
Chang, Xiaoyan
Wang, Chenghao
Zhang, Linyou
DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 1703 - 1719
[10] The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer
Arrieta, Oscar
Felipe Cardona, Andres
Corrales, Luis
Delia Campos-Parra, Alma
Sanchez-Reyes, Roberto
Amieva-Rivera, Eduardo
Rodriguez, July
Vargas, Carlos
Carranza, Hernan
Otero, Jorge
Karachaliou, Nikki
Astudillo, Horacio
Rosell, Rafael
LUNG CANCER, 2015, 87 (02) : 169 - 175

← 1 2 3 4 5 →